Statements (44)
Predicate | Object |
---|---|
gptkbp:instanceOf |
biotechnology company
|
gptkbp:acquisition |
gptkb:BioGen_Solutions
|
gptkbp:awardedBy |
Best_Biotech_Company_2021
|
gptkbp:employs |
over 500 people
|
gptkbp:founded |
2000
|
gptkbp:founder |
gptkb:Dr._Martin_Smith
|
gptkbp:hasAwards |
Innovative Research Award 2022
Sustainability Award 2023 |
gptkbp:hasClient |
gptkb:NutriBio
PharmaCorp EcoFarms AgriTech_Innovations MedHealth_Solutions |
gptkbp:hasCollaborationsWith |
gptkb:Stanford_University
gptkb:University_of_California |
gptkbp:hasEvents |
Community Outreach Program
Research Symposium 2023 Annual Biotech Conference Product Launch 2021 Investor Day 2022 |
gptkbp:hasFilm |
to be a leader in innovative biotech solutions.
|
gptkbp:hasMission |
to advance biotechnology for health and sustainability
|
gptkbp:hasPart |
research and development department
production facility |
gptkbp:hasProductLine |
GeneX
CellEnhancer VaccinePro |
gptkbp:hasResearchInterest |
$10 million from NIH
$5 million from EU |
gptkbp:hasResidence |
$200 million
|
gptkbp:hasSocialMedia |
@MartinBiotech_on_Twitter
Martin_Biotech_on_Facebook Martin_Biotech_on_LinkedIn |
gptkbp:hasTechnology |
CRISPR
synthetic biology biomanufacturing |
gptkbp:hasWebsite |
www.martinbiotech.com
|
gptkbp:headquarters |
gptkb:San_Francisco,_California
|
https://www.w3.org/2000/01/rdf-schema#label |
Martin Biotech
|
gptkbp:operatesIn |
gptkb:Asia
gptkb:North_America Europe |
gptkbp:partnerships |
gptkb:HealthCorp
|
gptkbp:specializesIn |
genetic engineering
|